News

September 18, 2009 – Patients’ response to anti-platelet therapy after percutaneous coronary intervention (PCI) and its impact on clinical outcomes will be covered in a TCT 2009 breakfast...

August, 13, 2009 – Atherotech Inc. this week added two new cardiometabolic tests – the PLAC Test for identification of increased heart attack and stroke risk, and the Cystatin C test as an early,...

July 22, 2009 – Roche Diagnostics today introduced the Roche Cardiac 200, a comprehensive testing solution for rapid cardiac diagnostic needs in point-of-care testing environments.

May 10, 2009 - Biosite and the FDA notified healthcare professionals of the Class 1 recall of the Biosite brand Triage Cardiac Panel, a test is used by as an aid in the diagnosis of a heart attack...

April 9, 2009 - According to research presented last week at ACC, patients with the CYP2C19*2 genotype had more ischemic events in the one year following percutaneous coronary intervention (PCI...

March 20, 2009 - BRAHMS AG of Hennigsdorf, Germany and Annapolis, MD, recently submitted a 510(k) file to the FDA to market its patented BRAHMS MR-proANP Kryptor Test used to find biomarkers for...

February 19, 2009 - Molecular diagnostic company TrimGen Corp. has received FDA 510(k) clearance to market its eQ-PCR LC Warfarin Genotyping kit, an assay used to aid identification of patients...

August 28, 2008 - Just ahead of the expected release of clinical practice guidelines on Familial Hypercholesterolaemia (FH) by the influential National Institute for Clinical Excellence (NICE),...

August 1, 2008 - Osmetech said this week at the American Association for Clinical Chemistry (AACC) 2008 Conference and Exhibition in Washington, D.C., that following receipt of its 510(k)...

July 22, 2008 - Osmetech today said it received FDA 510(k) clearance for its eSensor Warfarin Sensitivity Test to be used as an aid in the identification of patients at risk for increased...

July 22, 2008 - CyGene Laboratories Inc. this week is introducing StrokeScan, a genetic screening test aimed at identifying high risk individuals who have a family history of stroke,...

April 28, 2008 - Researchers at the University of Warwick have found a that the protein E-selectin is a marker for endothelial dysfunction and sub-clinical systemic inflammation, which can help...

April 3, 2008 - Corgenix Medical Corp. has entered into an agreement with Randox Laboratories, a UK-based diagnostic company, in a partnership designed to expand the processing technology and...